CHA News Article

FDA Allows Importing of Parenteral Nutrition Drugs

The U.S. Food and Drug Administration (FDA) announced late last week that injectable drugs used in total parenteral nutrition (TPN) and currently in critical shortage will be imported into the U.S. and available to patients immediately. The shortage of parenteral nutrition drugs experienced in the U.S. since late 2012 is largely the result of the voluntary shutdown of American Regent/Luitpold, a major manufacturer of injectable nutrition drugs. The company decided to cease operations temporarily to address quality issues that included particulate matter in its products.  Other U.S. manufacturers of TPN components are now working to increase supplies to further offset the supply shortage. More information is available at the FDA’s website.